Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Pfizer
Pheon Therapeutics
National Cancer Institute (NCI)
Takeda
Tempus AI
Sanofi
NRG Oncology
Elevation Oncology
Mirati Therapeutics Inc.
ABM Therapeutics Corporation
Inhibrx Biosciences, Inc
NantCell, Inc.
Washington University School of Medicine
Centre Hospitalier Henri Duffaut - Avignon
Fusion Pharmaceuticals Inc.
Rutgers, The State University of New Jersey
pharmaand GmbH
Fate Therapeutics
National Institutes of Health Clinical Center (CC)
Bristol-Myers Squibb
Montefiore Medical Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University Health Network, Toronto
Lumos Pharma
Pfizer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of Wisconsin, Madison
University of Wisconsin, Madison
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Yale University
CureOne
National Institutes of Health Clinical Center (CC)
Helsinn Healthcare SA
Washington University School of Medicine
Albert Einstein College of Medicine
Masonic Cancer Center, University of Minnesota
New York State Psychiatric Institute
Cornerstone Pharmaceuticals
Stanford University
Par Pharmaceutical, Inc.
AHS Cancer Control Alberta
Merck Sharp & Dohme LLC
Mirati Therapeutics Inc.
Amgen
Pfizer
Calando Pharmaceuticals